Prevalence and Associated Factors of Obesity and Overweight in Chinese Patients with Bipolar Disorder

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2022 Sep 23

PMID 36147966

Authors

Wenying Yi

Haibo Wu

Ruikeng Li

Haijing Li

Zhen Song

Shenglin She

Yingjun Zheng

Affiliations

Soon will be listed here.

Abstract

Object: Despite abundant literature demonstrating a high prevalence of obesity and overweight in people with bipolar disorder (BD), little is known about this topic in China. Therefore, we assessed the prevalence and associated factors of obesity and overweight among inpatients with BD in our hospital, one of the largest public psychiatric hospitals in China.

Methods: In this retrospective, cross-sectional study, 1,169 inpatients ≥18 years with BD during 2019 were included. Obesity was defined as having a BMI ≥25 kg/m, and overweight was defined as having a BMI from 23 kg/m to <25 kg/m. Binary logistic regression analysis was performed to identify factors associated with obesity and overweight.

Results: The prevalence of obesity and overweight was 21.0% and 32.2% in patients with BD, respectively. Compared to patients with overweight and normal weight, patients with obesity were older, had a longer duration of BD and a longer length of hospital stay, had a higher prevalence of diabetes and hypertension, and had a higher level of all metabolic indices, except for HDL cholesterol. Binary logistic regression analysis showed that duration of BD, uric acid, alanine aminotransferase (ALT), triglyceride, and LDL cholesterol were significantly associated with obesity, and male sex and uric acid level were significantly associated with overweight ( < 0.05).

Conclusions: Obesity and overweight were fairly prevalent in Chinese BD patients, and several factors were related to obesity and overweight. The results of the present study call for the need to implement early screening, prevention and interventions for obesity and overweight in patients with BD in China.

Citing Articles

Prevalence and Risk Factors of Comorbid Obesity in Chinese Patients with Bipolar Disorder.

Wu Q, Zhang X, Liu Y, Wang Y Diabetes Metab Syndr Obes. 2023; 16:1459-1469.

PMID: 37229353 PMC: 10203366. DOI: 10.2147/DMSO.S404127.

References

Pan X, Wang L, Pan A . Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021; 9(6):373-392. DOI: 10.1016/S2213-8587(21)00045-0. View

Kunutsor S, Seddoh D . Alanine aminotransferase and risk of the metabolic syndrome: a linear dose-response relationship. PLoS One. 2014; 9(4):e96068. PMC: 4004562. DOI: 10.1371/journal.pone.0096068. View

Kelishadi R, Hemati Z, Qorbani M, Motlagh M, Djalalinia S, Ahadi Z . Association of Alanine Aminotransferase With Different Metabolic Phenotypes of Obesity in Children and Adolescents: The CASPIAN-V Study. Front Endocrinol (Lausanne). 2020; 11:358. PMC: 7426651. DOI: 10.3389/fendo.2020.00358. View

Zhao W, Zhai Y, Hu J, Wang J, Yang Z, Kong L . Economic burden of obesity-related chronic diseases in Mainland China. Obes Rev. 2008; 9 Suppl 1:62-7. DOI: 10.1111/j.1467-789X.2007.00440.x. View

. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016; 387(10026):1377-1396. PMC: 7615134. DOI: 10.1016/S0140-6736(16)30054-X. View

Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View

Borghi C, Agabiti-Rosei E, Johnson R, Kielstein J, Lurbe E, Mancia G . Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med. 2020; 80:1-11. DOI: 10.1016/j.ejim.2020.07.006. View

Sanchez-Orti J, Balanza-Martinez V, Correa-Ghisays P, Selva-Vera G, Vila-Frances J, Magdalena-Benedito R . Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders. Acta Psychiatr Scand. 2022; 146(3):215-226. DOI: 10.1111/acps.13433. View

Calkin C, van de Velde C, Ruzickova M, Slaney C, Garnham J, Hajek T . Can body mass index help predict outcome in patients with bipolar disorder?. Bipolar Disord. 2009; 11(6):650-6. PMC: 3544930. DOI: 10.1111/j.1399-5618.2009.00730.x. View

10.

McElroy S, Frye M, Suppes T, Dhavale D, Keck Jr P, Leverich G . Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002; 63(3):207-13. DOI: 10.4088/jcp.v63n0306. View

11.

Zhang Y, Rao W, Zeng L, Lok G, Cui L, Li J . Prevalence and correlates of bipolar disorder in the adult population of Hebei province, China. J Affect Disord. 2019; 263:129-133. DOI: 10.1016/j.jad.2019.11.104. View

12.

He H, Hu C, Ren Z, Bai L, Gao F, Lyu J . Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of Disease Study 2017. J Psychiatr Res. 2020; 125:96-105. DOI: 10.1016/j.jpsychires.2020.03.015. View

13.

Zhang L, Wang Z, Wang X, Chen Z, Shao L, Tian Y . Prevalence of overweight and obesity in China: Results from a cross-sectional study of 441 thousand adults, 2012-2015. Obes Res Clin Pract. 2020; 14(2):119-126. DOI: 10.1016/j.orcp.2020.02.005. View

14.

Liu Y, Ling S, Lui L, Ceban F, Vinberg M, Kessing L . Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis. J Affect Disord. 2021; 300:449-461. DOI: 10.1016/j.jad.2021.12.110. View

15.

Qiu Y, Li S, Teng Z, Tan Y, Xu X, Yang M . Association between abnormal glycolipid level and cognitive dysfunction in drug-naïve patients with bipolar disorder. J Affect Disord. 2021; 297:477-485. DOI: 10.1016/j.jad.2021.10.100. View

16.

Soreca I, Fagiolini A, Frank E, Houck P, Thompson W, Kupfer D . Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res. 2007; 42(11):956-61. DOI: 10.1016/j.jpsychires.2007.10.009. View

17.

Grover S, Malhotra N, Chakrabarti S, Kulhara P . Metabolic syndrome in bipolar disorders. Indian J Psychol Med. 2012; 34(2):110-8. PMC: 3498771. DOI: 10.4103/0253-7176.101767. View

18.

Tsai S, Lee C, Kuo C, Chen C . A retrospective analysis of risk and protective factors for natural death in bipolar disorder. J Clin Psychiatry. 2006; 66(12):1586-91. DOI: 10.4088/jcp.v66n1215. View

19.

Zhang L, Cao X, Wang S, Zheng W, Ungvari G, Ng C . The prevalence of bipolar disorder in China: A meta-analysis. J Affect Disord. 2016; 207:413-421. DOI: 10.1016/j.jad.2016.08.062. View

20.

Aguglia A, Salvi V, Amerio A, Gari M, Dragogna F, Mencacci C . Number of episodes and duration of illness associated with hypertension and 10-year cardiovascular risk in patients with bipolar disorder type I. Psychiatry Res. 2022; 308:114344. DOI: 10.1016/j.psychres.2021.114344. View